Evaluation of Sentinel Lymph Nodes in Head and Neck Squamous Cell Carcinoma

NCT00911326 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

101

Enrollment

INDUSTRY

Sponsor class

Stopped The trial was terminated early based on an interim review by the Data and Safety Monitoring Committee for positive efficacy outcome and no safety concerns.

Conditions

Head and Neck Squamous Cell Carcinoma (HNSCC)

Interventions

DRUG: Lymphoseek

Sponsor

Navidea Biopharmaceuticals